title: [Oral administration of etoposide therapy in refractory malignant lymphoma and adult T cell lymphoma].
authors.affiliation: First Dept. of Internal Medicine, Kurume University, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Honda
authors.forename: S
authors.initials: S
authors.lastname: Osabe
authors.forename: K
authors.initials: K
authors.lastname: Yosida
authors.forename: E
authors.initials: E
authors.lastname: Nakamura
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
authors.forename: H
authors.initials: H
authors.lastname: Natori
authors.forename: K
authors.initials: K
authors.lastname: Oizumi
authors.forename: A
authors.initials: A
authors.lastname: Sakamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Imamura
authors.forename: K
authors.initials: K
authors.lastname: Naito
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015458:Leukemia, T-Cell / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D005047:Etoposide